Details werden geladen...
Cancer drug price cuts leave costly brands untouched - The Economic Times
Prices of several anti-cancer drugs are set to fall significantly starting November 9, offering some financial relief. However, the prices of top-selling patented treatments will remain unchanged after the revision by the NPPA. Generic cancer drugs will experience steep reductions, with some seeing over a 10-fold decrease in price. The Supreme Court is hearing petitions aimed at regulating high trade margins charged by hospitals.
Ähnliche Seiten
Cancer drug price cuts: NPPA revises MRPs of 543 brands, Keytruda unchanged - India Today
https://www.indiatoday.in/health/story/cancer-drug-price-cuts-nppa-revises-543-brands-keytruda-unchanged-3026710-2026-10-28
NPPA caps trade margins on 137 cancer drugs at 30%, revised prices from Nov 9 - The Economic Times
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/nppa-caps-trade-margins-on-137-cancer-drugs-at-30-revised-prices-from-nov-9/articleshow/135015811.cms
Experts red-flag cancer drug price cuts as patented therapies see zero relief, markups exceed benchmark | Today News
https://www.livemint.com/news/cancer-drug-price-cuts-patented-therapies-zero-relief-markups-exceed-benchmark-11793270804604.html
No price relief for Cancer patients as NPPA list shows no change in key drug MRPs
https://www.dnaindia.com/india/report-cancer-drug-prices-key-medicines-like-keytruda-tagrisso-see-no-change-from-november-9cancer-drug-prices-key-medicines-like-keytruda-tagrisso-see-no-change-from-november-9-3223225Centre caps trade margins on 137 cancer drugs, prices likely to fall by up to 70% | Mint
https://www.livemint.com/industry/centre-caps-trade-margins-on-137-cancer-drugs-prices-likely-fall-by-up-to-70-11792248570646.html